July 18, 2014
RegMed gains strength on Friday
July 16, 2014
Higher open expected; RegMed gets blind-sided by the Fed
July 13, 2014
Clear and Present Dangers
July 10, 2014
Lower open expected; RegMed hasn’t been speaking to its believers
June 27, 2014
Lower open expected; RegMed boredom envelops the sector
June 20, 2014
StemCells (STEM) has positive data from P1/2 Dry Age-Related Macular Degeneration Trial – SELL on news
June 19, 2014
StemCells (STEM) trial shows positive interim results - HOLD
June 12, 2014
RegMed should start looking at out-of-control operating expense
June 12, 2014
Cytori (CYTX) appoints and nominates new BOD members
June 11, 2014
Cytori (CYTX) directors make trades
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.